Insider · CIK 0001960154

Jung Cassie

Reports to the SEC for 1 company · WARREN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001960154

Forms 4 and 5

Insider transactions

30 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-03	AQSTAquestive Therapeutics, Inc.X Exercise of In-Money	Chief Operating Officer	XExercise of In-Money	+4,587 sh	$0.96	+$4,403.52	206,833
2026-09-03	AQSTAquestive Therapeutics, Inc. · Warrant (Right to Buy)X Exercise of In-Money	Chief Operating Officer	XExercise of In-Money	−4,587 sh	—	—	0
2026-05-05	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−72.7K sh	$4.18	−$304K	202,246
2026-03-10	AQSTAquestive Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−45.8K sh	$4.17	−$191K	274,980
2026-03-09	AQSTAquestive Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+80K sh	—	—	320,771
2026-03-09	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+42.5K sh	—	—	42,500
2025-10-15	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+25K sh	$3.10	+$77.6K	308,346
2025-10-15	AQSTAquestive Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−67.6K sh	$7.01	−$474K	240,771
2025-10-15	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−25K sh	—	—	0
2025-09-04	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+25K sh	$3.15	+$78.8K	320,526
2025-09-04	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+25K sh	$0.71	+$17.7K	345,526
2025-09-04	AQSTAquestive Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−62.2K sh	$5.00	−$311K	283,346
2025-09-04	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−25K sh	—	—	0
2025-09-04	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−25K sh	—	—	0
2025-03-10	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−2,182 sh	$2.54	−$5,542.28	295,526
2025-03-09	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−7,997 sh	$2.65	−$21.2K	297,708
2025-03-07	AQSTAquestive Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+80K sh	—	—	313,066
2025-03-07	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−7,361 sh	$2.65	−$19.5K	305,705
2025-03-07	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+40K sh	—	—	40,000
2025-03-07	AQSTAquestive Therapeutics, Inc. · Performance Stock UnitsA Award	Chief Operating Officer	AAward	+60K sh	—	—	60,000
2024-11-26	AQSTAquestive Therapeutics, Inc.S Sale	Chief Operating Officer	SSale	−44 sh	$4.87	−$214.06	0
2024-03-10	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−1,132 sh	$4.88	−$5,524.16	237,754
2024-03-09	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−14.1K sh	$4.88	−$68.9K	233,066
2024-03-09	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−8,300 sh	$4.88	−$40.5K	238,886
2024-03-07	AQSTAquestive Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+101K sh	—	—	247,186
2024-03-07	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+50.6K sh	—	—	50,625
2023-08-09	AQSTAquestive Therapeutics, Inc. · Performance Stock UnitsA Award	Chief Operating Officer	AAward	+55K sh	—	—	55,000
2023-05-05	AQSTAquestive Therapeutics, Inc. · Performance Stock UnitsA Award	Chief Operating Officer	AAward	+55K sh	—	—	55,000
2023-03-10	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Operating Officer	FTax Payment	−1,365 sh	—	—	145,936
2023-03-09	AQSTAquestive Therapeutics, Inc.A Award	Chief Operating Officer	AAward	+110K sh	—	—	146,747

Recent filings

Accepted (ET)
Sep 84
Jung Cassie0001214659-26-011475
SEC(opens sec.gov)
May 74
Jung Cassie0001214659-26-005748
SEC(opens sec.gov)
Apr 134
Jung Cassie0001214659-26-004595
SEC(opens sec.gov)
Mar 114
Jung Cassie0001214659-26-003141
SEC(opens sec.gov)
Oct 174
Jung Cassie0001214659-25-015048
SEC(opens sec.gov)
Sep 84
Jung Cassie0001214659-25-013493
SEC(opens sec.gov)
Mar 114
Jung Cassie0001214659-25-004227
SEC(opens sec.gov)

Companies

Aquestive Therapeutics, Inc.Chief Operating OfficerAQST

Address

C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE

WARREN, NJ, 07059